This report analyzes the strategies and sustainability of AstraZeneca in the pharmaceutical industry, including a SWOT analysis and key findings. It discusses the company's internal approaches, VRIO analysis, and the use of Porter's generic strategies. The report also highlights the challenges posed by the COVID-19 pandemic and provides recommendations for the company's future growth.